Picture only for representation Photo Credit: Getty Images
Indian annual drug and pharmaceutical exports touched a record $ 30 billion in FY25 reinforced 31% year -on -year increase in March.
At $ 30467.32 million, exports were $ 9.39% greater than $ 27851.70 million in FY24, and recently showed official business data.
Export Pharma first touched $ 30 billion. Target FY25 was $ 29.38 billion, said Raja Bhan, the director of the export export council.
March Performance
Březno performance excelled in fiscal, which will remember the development on the main US market, although India continued to use and build on the initial profits of new markets. If the lack of generic prescription drugs in the US raised hope initially in the fiscal year, at the end of the year, the reciprocal 26% of the Donald Trump tariff threatened to show that the exporters would become more to send more. However, the Pharma is not displayed in the list of goods for which it was announced and subjected to 90 days.
In March, Pharma’s export increased by $ 31.21 to $ 3681.51 million ($ 2805.71 million). Another best performance during Fiscal came in January, when exports increased by $ 21.47 to $ 259.88 million ($ 2132.92 million). May was the second month, when growth touched double digits (10.63% to $ 2305.56 million), while February was the only month of downloading 1.52% to $ 2474.22 million).
In addition to the American factor, the export of FY25 became the face of geopolitical tension, economic slowdown and logistics challenges.
Product category
Granular details for March are expected, Pharmexcil DG said. Data for April-February show drug formulations and biological substances as a product category led with 20118.18 million 20118.18 million and accounted for more than 75% of total exports. This category has expanded by almost 9%year -on -year.
The exports of mass drugs and intermediate products were the highest, in 11 months they increased by 1.40% to $ 4319.30 million. Although the third largest exported category, among pharmaceutical products, the value of vaccine exports decreased by 4.20% to $ 1043.76 million.
The export of surgical substances increased by 5.16% and the export value was 683.47 million USD. Ayush export and herbal products increased by 6.17% to $ 620.97 million. The total export of Pharma by February increased this fiscal by 6.95% to $ 26785.69 million.
US The highest market
The US, which remains the largest market for years, has now maintained their dominant accounting for more than a third of the Indian export of the pharmacy. In terms of value, exports to the US were 14.29% to $ 89537 million ($ 7833.75 million). The United Kingdom, Brazil, France and South Africa were another in the top five countries that were together for less than 10.5% of exports.
Also read: USA tariffs on cars focus on India Pharma
South Africa, on the other hand, was on the list despite the decline in exports by 1.78%. During the 11 months of the fiscal market, the 25 best countries where exports have decreased were the United Arab Emirates (by 17.70%); Turkey (16%); Sri Lanka (14.60%); Netherlands (13.79%), China (10.60%) and Belgium (7.37%). The decline in exports was 3.80% to Mexico and 0.14% to Thailand, they showed official data.
Upper regions
RegionWise, diesel, Europe, Africa and Lac were four main regions that represented 76% of Indian exports of the pharmacy. Of these, diesel was 36.60%, exporting by 14.06% to $ 9804.78 million.
Among the regions where exports decreased were Africa (by 1.74%) and northeast Asia (4.30%).
Published – April 18 2025 23:11
